Characteristics of patients with AML with and without MK who received a transplant and associated 4-year OS
| . | No MK . | MK . | ||
|---|---|---|---|---|
| n (%) . | 4-y OS, % . | n (%) . | 4-y OS, % . | |
| All patients | 372 (86) | 56 | 60 (14) | 25 |
| Age | ||||
| 0-40 y | 128 (91) | 63 | 12 (9) | 56 |
| 41-60 y | 170 (85) | 57 | 31 (15) | 28 |
| 61-80 y | 74 (81) | 44 | 17 (19) | 6 |
| Sex | ||||
| Male | 198 (86) | 53 | 31 (14) | 30 |
| Female | 174 (86) | 61 | 29 (14) | 18 |
| Cytogenetic risk before treatment | ||||
| Good | 30 (100) | 48 | 0 | |
| Intermediate | 254 (100) | 59 | 0 | |
| Poor | 88 (59) | 52 | 60 (41) | 25 |
| Monosomy | ||||
| −7 | 16 (32) | 41 | 34 (68) | 26 |
| −17 | 0 | 19 | 13 | |
| −18 | 0 | 17 | 20 | |
| − 5 | 0 | 15 | 0 | |
| −13 | 1 | 13 | 39 | |
| Complex | ||||
| No | 349 (95) | 57 | 17 (5) | 46 |
| Yes | 23 (35) | 51 | 43 (65) | 17 |
| Remission | ||||
| First remission | 193 (45) | 65 | 35 (8) | 30 |
| Second remission | 97 (22) | 54 | 4 (1) | 25 |
| All others | 82 (19) | 39 | 21 (5) | 16 |
| . | No MK . | MK . | ||
|---|---|---|---|---|
| n (%) . | 4-y OS, % . | n (%) . | 4-y OS, % . | |
| All patients | 372 (86) | 56 | 60 (14) | 25 |
| Age | ||||
| 0-40 y | 128 (91) | 63 | 12 (9) | 56 |
| 41-60 y | 170 (85) | 57 | 31 (15) | 28 |
| 61-80 y | 74 (81) | 44 | 17 (19) | 6 |
| Sex | ||||
| Male | 198 (86) | 53 | 31 (14) | 30 |
| Female | 174 (86) | 61 | 29 (14) | 18 |
| Cytogenetic risk before treatment | ||||
| Good | 30 (100) | 48 | 0 | |
| Intermediate | 254 (100) | 59 | 0 | |
| Poor | 88 (59) | 52 | 60 (41) | 25 |
| Monosomy | ||||
| −7 | 16 (32) | 41 | 34 (68) | 26 |
| −17 | 0 | 19 | 13 | |
| −18 | 0 | 17 | 20 | |
| − 5 | 0 | 15 | 0 | |
| −13 | 1 | 13 | 39 | |
| Complex | ||||
| No | 349 (95) | 57 | 17 (5) | 46 |
| Yes | 23 (35) | 51 | 43 (65) | 17 |
| Remission | ||||
| First remission | 193 (45) | 65 | 35 (8) | 30 |
| Second remission | 97 (22) | 54 | 4 (1) | 25 |
| All others | 82 (19) | 39 | 21 (5) | 16 |